3F-PiHP
3F-PiHP is a synthetic stimulant of the cathinone class. It is chemically related to Pyrovalerone and is known for its psychoactive effects. The compound is a fluorinated derivative of α-Pyrrolidinohexiophenone (α-PHP), where the hydrogen atom at the para position of the phenyl ring is replaced by a fluorine atom.
Chemical Structure and Properties[edit | edit source]
3F-PiHP, or 3-Fluoro-α-Pyrrolidinohexiophenone, has the chemical formula C16H22FNO. It features a pyrrolidine ring attached to a hexanone chain, with a fluorine atom at the third position of the phenyl ring. This structural modification is believed to influence its pharmacological properties and potency.
Pharmacology[edit | edit source]
As a member of the cathinone class, 3F-PiHP acts as a central nervous system stimulant. It is thought to exert its effects by increasing the levels of dopamine, norepinephrine, and serotonin in the brain, similar to other synthetic cathinones. However, detailed studies on its pharmacodynamics and pharmacokinetics are limited.
Effects and Usage[edit | edit source]
Users of 3F-PiHP report effects such as increased energy, euphoria, and enhanced focus. However, it can also cause adverse effects like anxiety, paranoia, and cardiovascular issues. Due to its potent stimulant properties, it is often used recreationally, but it carries significant risks of addiction and adverse health effects.
Legal Status[edit | edit source]
The legal status of 3F-PiHP varies by country. In many jurisdictions, it is classified as a controlled substance due to its potential for abuse and lack of medical use. It is important to consult local regulations to determine its legal status in a specific area.
Safety and Risks[edit | edit source]
The use of 3F-PiHP is associated with several health risks, including cardiovascular problems, neurological effects, and potential for addiction. Due to the lack of comprehensive research, the long-term effects of 3F-PiHP use are not well understood. Users are advised to exercise caution and be aware of the potential for serious adverse effects.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
